0 (0%)		11-11 19:25
Open: High: Volume: 0		Pre. Close: Low: Market Cap: 0(M)

Short term
Mid term
Targets	6-month :	39.46	1-year :	46.08
Resists	First :	33.78	Second :	39.46
Pivot price	32.87
Supports	First :	32.1	Second :	31.05
MAs	MA(5) :	33.44	MA(20) :	32.5
	MA(100) :	31.68	MA(250) :	30.05
MACD	MACD :	0.3	Signal :	0.2
%K %D	K(14,3) :	92.8	D(3) :	91.7
RSI	RSI(14): 68.5
52-week	High :	33.78	Low :	25.73

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ RNDV ] has closed below upper band by 10.1%. Bollinger Bands are 42.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 19 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	33.83 - 33.95	33.95 - 34.05
Low:	33.21 - 33.37	33.37 - 33.5
Close:	33.54 - 33.79	33.79 - 33.99

Thu, 09 Oct 2025
RNDV Industries Crowned ScaffChamp 2025 Champions | - Scaffmag

Thu, 24 Jul 2025
Philippine Labor Officials Visit Lithuanian Companies Amid OFW Hiring Boom - The Filipino Times

Fri, 11 Apr 2025
Eradicating the common mistake that can lead to higher construction costs - Construction Management Magazine

Tue, 30 Jul 2024
Safety evaluation of recombinant Newcastle disease virus expressing IBV multi-epitope chimeric live vaccine - Frontiers

Thu, 04 Jan 2024
The artificial amino acid change in the sialic acid-binding domain of the hemagglutinin neuraminidase of newcastle disease virus increases its specificity to HCT 116 colorectal cancer cells and tumor suppression effect - Virology Journal

Mon, 16 Oct 2023
The tumor suppressive effect and apoptotic mechanism of TRAIL gene-containing recombinant NDV in TRAIL-resistant colorectal cancer HT-29 cells and TRAIL-nonresistant HCT116 cells, with each cell bearing a mouse model - Wiley Online Library

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange:
Sector:
Industry:
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.